Bis[1,2-bis(diphenylphosphino)ethane]palladium(0)
Product Information
Molecular Formula
[(C6H5)2PCH2CH2P(C6H5)2]2Pd
Molecular Weight
903.25
Description
Bis[1,2-bis(diphenylphosphino)ethane]palladium(0) is widely utilized in the biomedical industry as a catalyst for various organic transformations. It plays a crucial role in synthesizing drugs, such as anti-cancer agents, by facilitating critical reactions. Additionally, Bis[1,2-bis(diphenylphosphino)ethane]palladium(0) is involved in the development of innovative therapies for neurodegenerative diseases through its catalytic properties
Synonyms
Bis(DIPHOS)palladium(0), Pd(DIPHOS)2, Pd(dppe)2
IUPAC Name
2-diphenylphosphanylethyl(diphenyl)phosphanepalladium
SMILES
C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4.[Pd]
InChI
InChI=1S/2C26H24P2.Pd/c2*1-5-13-23(14-6-1)27(24-15-7-2-8-16-24)21-22-28(25-17-9-3-10-18-25)26-19-11-4-12-20-26/h2*1-20H,21-22H2
InChI Key
FAFGMAGIYHHRKN-UHFFFAOYSA-N
Flash Point
Not applicable
Storage
−20°C
Safety Information
Hazards
H302 + H312 + H332
Precautionary Statement
P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
0
Rotatable Bond Count
14
Exact Mass
902.17413 g/mol
Monoisotopic Mass
902.17413 g/mol
Topological Polar Surface Area
0Ų
Heavy Atom Count
57
Formal Charge
0
Complexity
336
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
3
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021248909-A1 | Isoquinoline compound, manufacturing method therefor, and application thereof | 2020-06-12 |
| JP-2021187753-A | Method for producing 2,3,4,5,6-pentafluorostyrene | 2020-05-27 |
| WO-2021209415-A1 | Hydrogenation of l-sorbose | 2020-04-14 |
| JP-2020117517-A | Method for producing 2-amino-1-(pyridin-2-yl)ethanone compound | 2020-03-30 |
| WO-2021142155-A1 | Processes for preparing triazole glycolate oxidase inhibitors | 2020-01-08 |
| CN-110964178-A | Two-dimensional fully conjugated polymer and preparation method and application thereof | 2019-11-05 |
| WO-2021067670-A1 | Process for preparing an activin receptor-like kinase inhibitor | 2019-10-02 |
| WO-2021062035-A1 | Luminescent materials and methods thereof | 2019-09-27 |
| WO-2020239073-A1 | Fused ring compound, preparation method therefor and use thereof | 2019-05-30 |
| WO-2020161175-A1 | Process for the production of acetals from carbon dioxide | 2019-02-06 |
